Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Leukemia | D007938 | — | C95 | — | — | 1 | — | — | 1 |
Myelodysplastic syndromes | D009190 | — | D46 | — | — | 1 | — | — | 1 |
Myeloid leukemia acute | D015470 | — | C92.0 | — | — | 1 | — | — | 1 |
Congenital abnormalities | D000013 | EFO_0003915 | Q89.9 | — | — | 1 | — | — | 1 |
Megakaryoblastic leukemia acute | D007947 | — | C94.2 | — | — | 1 | — | — | 1 |
Monocytic leukemia acute | D007948 | — | — | — | — | 1 | — | — | 1 |
Myelomonocytic leukemia acute | D015479 | — | C92.5 | — | — | 1 | — | — | 1 |
Refractory anemia with excess of blasts | D000754 | — | D46.2 | — | — | 1 | — | — | 1 |
Erythroblastic leukemia acute | D004915 | EFO_1001257 | C94.0 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 2 | 2 | — | — | — | 3 |
Neuroblastoma | D009447 | EFO_0000621 | — | 1 | 1 | — | — | — | 1 |
Recurrence | D012008 | — | — | — | 1 | — | — | — | 1 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | — | — | — | 1 |
Small cell lung carcinoma | D055752 | — | — | — | 1 | — | — | — | 1 |
Drug common name | Cilmostim |
INN | cilmostim |
Description | Cilmostim is a protein pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Protein |
Drug class | colony-stimulating factors: macrophage colony-stimulating factors (M-CSF) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2108239 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | EWL6971ETP (ChemIDplus, GSRS) |